172 related articles for article (PubMed ID: 3008363)
21. Analysis of risk factors for hepatocellular carcinoma in patients with HBs antigen- and anti-HCV antibody-negative alcoholic cirrhosis: clinical significance of prior hepatitis B virus infection.
Uetake S; Yamauchi M; Itoh S; Kawashima O; Takeda K; Ohata M
Alcohol Clin Exp Res; 2003 Aug; 27(8 Suppl):47S-51S. PubMed ID: 12960507
[TBL] [Abstract][Full Text] [Related]
22. Lack of spontaneous and inducible natural killer cell activity in human bone marrow: presence of adherent suppressor cells.
Uchida A
Nat Immun Cell Growth Regul; 1983-1984; 3(4):181-92. PubMed ID: 6241292
[TBL] [Abstract][Full Text] [Related]
23. Impact of hepatitis B and C virus infection on the clinical prognosis of alcoholic liver cirrhosis.
Yamanaka T; Shiraki K; Nakazaawa S; Okano H; Ito T; Deguchi M; Takase K; Nakano T
Anticancer Res; 2001; 21(4B):2937-40. PubMed ID: 11712790
[TBL] [Abstract][Full Text] [Related]
24. Effect of anergy on short-lived suppressor cells in patients with cirrhosis or peripheral vascular disease.
Ulrich F; Gander S; Johnson WC
J Clin Lab Immunol; 1984 Apr; 13(4):161-5. PubMed ID: 6234398
[TBL] [Abstract][Full Text] [Related]
25. [The behavior of the HBeAg-anti-HBe system in chronic hepatitis].
Musca A; Cordova C; Barnaba V; Bonavita MS; Zaccari C; Levrero M
Minerva Dietol Gastroenterol; 1983; 29(1):19-26. PubMed ID: 6843853
[No Abstract] [Full Text] [Related]
26. [Comparative study of the "e" system (HBeAG/anti-HBeAg) and core antibodies in aggressive chronic hepatitis and liver cirrhosis].
Marinucci G; Muglia M; Di Giacomo C; Petrucci L; Mancini R; Costa F; Bachetoni A
Quad Sclavo Diagn; 1981 Mar; 17(1):81-5. PubMed ID: 7313073
[No Abstract] [Full Text] [Related]
27. Decreased suppressor T cell activity in patients with hepatic cirrhosis (HC).
Tomino S; Fujiwara H; Kagimoto T; Mitsuya H; Nishimura H; Kishimoto S
Clin Exp Immunol; 1982 Jun; 48(3):625-32. PubMed ID: 6214341
[TBL] [Abstract][Full Text] [Related]
28. Survival in hepatitis-B cirrhosis compared to alcoholic cirrhosis in patients with Child's C liver disease: a prospective study of endoscopic sclerotherapy for bleeding oesophageal varices.
Lee SM; Wong NW
Singapore Med J; 1994 Feb; 35(1):53-6. PubMed ID: 8009280
[TBL] [Abstract][Full Text] [Related]
29. Hepatitis B surface antigen in cirrhosis of liver.
Sharma VK; Prasad FC
J Indian Med Assoc; 1985 Sep; 83(9):305-7. PubMed ID: 4086851
[No Abstract] [Full Text] [Related]
30. Impaired concanavalin A-inducible suppressor T-cell activity in active alcoholic liver disease.
Kawanishi H; Tavassolie H; MacDermott RP; Sheagren JN
Gastroenterology; 1981 Mar; 80(3):510-7. PubMed ID: 6450078
[TBL] [Abstract][Full Text] [Related]
31. Bone marrow mesenchymal stromal cells (BM-MSCs) from healthy donors and auto-immune disease patients reduce the proliferation of autologous- and allogeneic-stimulated lymphocytes in vitro.
Bocelli-Tyndall C; Bracci L; Spagnoli G; Braccini A; Bouchenaki M; Ceredig R; Pistoia V; Martin I; Tyndall A
Rheumatology (Oxford); 2007 Mar; 46(3):403-8. PubMed ID: 16920750
[TBL] [Abstract][Full Text] [Related]
32. [Early cirrhosis, an early modality of the evolution of acute hepatitis. The clinico-biological, immunological and morphological aspects].
Banciu T; Tudose N; Arcan P
Rev Med Interna Neurol Psihiatr Neurochir Dermatovenerol Med Interna; 1990; 42(2):167-74. PubMed ID: 1982190
[TBL] [Abstract][Full Text] [Related]
33. [Modern clinical picture of the problem of hepatitis and cirrhosis].
Tareev EM
Sov Med; 1977 Dec; (12):3-14. PubMed ID: 341353
[No Abstract] [Full Text] [Related]
34. Dysregulation of blood lymphocyte subsets and natural killer cells in schistosomal liver cirrhosis and hepatocellular carcinoma.
Attallah AM; Tabll AA; El-Sadany M; Ibrahim TA; El-Dosoky I
Clin Exp Med; 2003 Nov; 3(3):181-5. PubMed ID: 14648234
[TBL] [Abstract][Full Text] [Related]
35. CD4+CD25+FOXP3+ T regulatory cells reconstitute and accumulate in the bone marrow of patients with multiple myeloma following allogeneic stem cell transplantation.
Atanackovic D; Cao Y; Luetkens T; Panse J; Faltz C; Arfsten J; Bartels K; Wolschke C; Eiermann T; Zander AR; Fehse B; Bokemeyer C; Kroger N
Haematologica; 2008 Mar; 93(3):423-30. PubMed ID: 18287134
[TBL] [Abstract][Full Text] [Related]
36. Cryptogenic cirrhosis: clinico-biochemical comparison with alcoholic and viral etiologies.
Strauss E; Lacet CM; Caly WR; Fukushima JT; Gayotto LC
Arq Gastroenterol; 1990; 27(2):46-52. PubMed ID: 2094182
[TBL] [Abstract][Full Text] [Related]
37. [The systemic and local immune responses in patients with alcoholic liver cirrhosis depending on hepatitis C viral infection (HCV)].
Kolarski V; Petrova D; Naumova E; Mikhaĭlova A; Teokharov P; Dzhonova D; Todorov A; Slavchev B; Diankova L
Vutr Boles; 1999; 31(1):23-7. PubMed ID: 10847145
[TBL] [Abstract][Full Text] [Related]
38. Researches on viral hepatitis markers correlated with pathomorphological and clinical aspects in chronic hepatitis.
Brehar-Cioflec D; Vajda A; Negrea DA; Străin R; Tudose N; Sporea I; Moldovan R; Chidioşan C; Chirileanu O; Gaiţă-Criveanu D
Rom J Virol; 1995; 46(3-4):107-13. PubMed ID: 9179963
[TBL] [Abstract][Full Text] [Related]
39. Hepatitis C virus, alcoholic cirrhosis, and hepatocellular carcinoma.
Goeser T; Müller HM; Solbach C; Toex U; Kommerell B; Theilmann L
Cancer Epidemiol Biomarkers Prev; 1994 Jun; 3(4):311-5. PubMed ID: 8061579
[TBL] [Abstract][Full Text] [Related]
40. Serum iron parameters in patients with alcoholic and chronic cirrhosis and hepatitis.
Jurczyk K; Wawrzynowicz-Syczewska M; Boroń-Kaczmarska A; Sych Z
Med Sci Monit; 2001; 7(5):962-5. PubMed ID: 11535942
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
